RLX-201 is a lab-made relative of rapamycin, a drug studied in aging research, used as a skincare ingredient in a single face serum aimed at aging skin. One trial of the serum, run by its maker, found firmer, smoother, more radiant skin than the plain base formula. The evidence is thin and comes from one source; no side effects were recorded in twelve weeks, and long-term safety remains unknown. (Full Review)

Protocol

Manufacturer regimen

1–2 pumps, morning and night

To clean, dry skin, before other serums or moisturizer; one retailer lists 1 pump

Trial regimen

Twice daily, whole face, 12 weeks

Applied after an SPF 30 moisturizer in the morning and a moisturizing lotion at night

Procedure-priming approach

2–4 weeks of use before peels or lasers

Stopping 2 days before, restarting after healing; alternatively 2–3 months of use, stopping at least 2 weeks before

Time to effect

Firmness

By week 2

Separated from vehicle (serum base)

Sagging & around-the-eye elasticity

Weeks 8–12

Judging results before 8–12 weeks may be premature

Radiance

By week 4

Exceeded vehicle from week 4 through week 12

Benefits

Low: Firmer, more elastic skin with less sagging; smoother texture and fewer fine lines; brighter, more radiant skin

Speculative: Dermal collagen and elastin rebuilding; rejuvenated fibroblast behavior; reduced facial redness; better response to laser, light and filler procedures; whole-body longevity effects

Contraindications

Pregnant or breastfeeding women (theoretical)

Active bacterial, viral or fungal skin infection, open wounds, or skin still healing from a procedure (theoretical)

Systemic immunosuppressive medications within the past 3 months (theoretical)

Autoimmune connective-tissue disease (lupus, scleroderma, dermatomyositis) (theoretical)

Known hypersensitivity to sirolimus or any serum ingredient (theoretical)

Key Interactions

Oral mTOR inhibitors (sirolimus, everolimus, off-label low-dose rapamycin): caution (theoretical)

Prescription topical retinoids (tretinoin, tazarotene, adapalene): monitor (theoretical)

Topical calcineurin inhibitors (tacrolimus ointment, pimecrolimus cream): caution (theoretical)

Strong CYP3A4 or P-glycoprotein inhibitors (ketoconazole, clarithromycin, itraconazole): monitor (theoretical)

Exfoliating acids and scrubs (glycolic acid, salicylic acid, benzoyl peroxide): caution (theoretical)

Hydrocortisone cream: monitor (theoretical)

Supplements reported to lower mTORC1 signaling (resveratrol, curcumin, berberine, EGCG (a green tea compound)): monitor (theoretical)

Topical vitamin C, peptides and exosomes: monitor (theoretical)

Lasers, chemical peels, microneedling and intense pulsed light: caution (theoretical)

Fillers and collagen biostimulators (injectables that prompt the skin to make collagen): monitor (theoretical)

Risk & Side Effects

Low: Dryness and local irritation; slower healing of wounds and procedure sites; local skin infection; allergic reaction to the molecule or co-ingredients

Speculative: Harm to a developing fetus; systemic metabolic effects; unknown long-term effects

Monitoring

Marker	Target	Why
Pregnancy test (urine hCG), only for women who could become pregnant	Negative	Safety check: a positive result stops use
Skin elasticity (suction elastometry)	No established target; track change from own baseline	Expected to change with use
Photoaging grade (Griffiths 10-point scale)	No established target; track change from own baseline	Expected to change with use
Standardized facial photography (cross-polarized imaging)	No established target; compare with own baseline images	Expected to change: wrinkles, tone, redness

Cadence: Baseline before starting; reassess at 4, 8 and 12 weeks, then every 3–6 months while use continues; tolerability checked at each visit and after any new product is added

Qualitative Assessment

Firmness and "bounce" of the skin
Radiance and evenness of tone
Texture and fine lines
Facial redness or flushing
Dryness, stinging or irritation
Healing speed of minor cuts or after procedures

RLX-201 for Skin Rejuvenation

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment